Showing 1 - 6 results of 6 for search 'Aranzazu González-del-Alba', query time: 0.03s Refine Results
  1. 1
    Management of Patients with Metastatic Bladder Cancer in the Real-World Setting from the Multidisciplinary Team: Current Opinion of the SOGUG Multidisciplinary Working Group

    Management of Patients with Metastatic Bladder Cancer in the Real-World Setting from the Multidisciplinary Team: Current Opinion of the SOGUG Multidisciplinary Working Group by Aránzazu González-del-Alba, Antonio José Conde-Moreno, Ana M. García Vicente, Pilar González-Peramato, Estefanía Linares-Espinós, Miguel Ángel Climent, the SOGUG Multidisciplinary Working Group

    Published 2022-02-01
    Get full text
    Article
  2. 2
    Expert recommendations on the management of patients with metastatic castration-resistant prostate cancer who progress after CHAARTED or LATITUDE

    Expert recommendations on the management of patients with metastatic castration-resistant prostate cancer who progress after CHAARTED or LATITUDE by Javier Puente, Urbano Anido, Miguel Ángel Climent, Enrique Gonzalez-Billalabeitia, Nuria Lainez, Julio Lambea, José Pablo Maroto, Maria Jose Mendez-Vidal, Álvaro Montesa, Angel Rodriguez, Curro Zambrana, Aránzazu González-del-Alba

    Published 2020-05-01
    Get full text
    Article
  3. 3
    Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO)

    Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer:... by Javier Puente, Aranzazu González-del-Alba, Núria Sala-Gonzalez, María José Méndez-Vidal, Alvaro Pinto, Ángel Rodríguez, José Miguel Cuevas Sanz, Jacobo Rodrigo Muñoz del Toro, Eduardo Useros Rodríguez, Ángela García García-Porrero, Sergio Vázquez

    Published 2019-08-01
    Get full text
    Article
  4. 4
    Epithelial-to-Mesenchymal Transition Mediates Resistance to Maintenance Therapy with Vinflunine in Advanced Urothelial Cell Carcinoma

    Epithelial-to-Mesenchymal Transition Mediates Resistance to Maintenance Therapy with Vinflunine in Advanced Urothelial Cell Carcinoma by Albert Font, Vicenç Ruiz de Porras, Begoña P. Valderrama, Jose Luis Ramirez, Lara Nonell, José Antonio Virizuela, Urbano Anido, Aránzazu González-del-Alba, Nuria Lainez, Maria del Mar Llorente, Natalia Jiménez, Begoña Mellado, Jesus García-Donas, Joaquim Bellmunt

    Published 2021-12-01
    Get full text
    Article
  5. 5
    Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors

    Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors by María Torrente, María Torrente, Mariola Blanco, Fabio Franco, Yago Garitaonaindia, Virginia Calvo, Ana Collazo-Lorduy, Lourdes Gutiérrez, Juan Cristóbal Sánchez, Aranzazu González-del-Alba, Roberto Hernández, Miriam Méndez, Blanca Cantos, Beatriz Núñez, Pedro A. C. Sousa, Mariano Provencio

    Published 2022-12-01
    Get full text
    Article
  6. 6
    Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma.

    Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma. by Celia Prior, Jose Luis Perez-Gracia, Jesus Garcia-Donas, Cristina Rodriguez-Antona, Elizabeth Guruceaga, Emilio Esteban, Cristina Suarez, Daniel Castellano, Aránzazu González del Alba, Maria Dolores Lozano, Joan Carles, Miguel Angel Climent, Jose Angel Arranz, Enrique Gallardo, Javier Puente, Joaquim Bellmunt, Alfonso Gurpide, Jose Maria Lopez-Picazo, Alvaro Gonzalez Hernandez, Begoña Mellado, Esther Martínez, Fernando Moreno, Albert Font, Alfonso Calvo

    Published 2014-01-01
    Get full text
    Article

Search Tools: